Xenetic Biosciences -CW24XBIOWPreferred / convertible
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$14.00avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Xenetic Biosciences -CW24 (XBIOW) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was UBS Group AG ($14).
- Company
- Xenetic Biosciences -CW24
- CUSIP
- 984015131
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| UBS Group AG | — | No change | 1 | $14 |
"% of holder's portfolio" is XBIOW's weight in each manager's 13F, not the share of Xenetic Biosciences -CW24 the manager owns.